Qiagen, the new giant in next-gen sequencing tools?
Yet again, a new acquisition in this beginning of 2015. Enzymatics, the Boston-area based Biotech company and…
Yet again, a new acquisition in this beginning of 2015. Enzymatics, the Boston-area based Biotech company and…
Heraeus Medical signed an agreement with Locate Therapeutics to license the intellectual property surrounding the use…
What could you buy with €1,1M euros? A house? Or a single prescription for a new…
Oxford BioTherapeutics and Menarini Group have initiated the first-in-human clinical study of OBT357, a novel enhanced…
Curetis AG, a developer of next-level molecular diagnostic solutions, has closed a EUR 14.5 million extension of…
The biotech sector in the Greater Munich area continues to demonstrate significant growth in revenue…
Pharmaceutical giants Merck and Pfizer have agreed a deal to develop and market immunotherapy agents…
The title may seem a bit catchy, but that’s what lot of companies told me during…
The first outbreaks of Ebola (also known as Ebola haemorrhagic fever) have occurred in isolated…
A novel concept of fully personalized therapeutic cancer vaccines, called Glioma Actively Personalized VAccine Consortium…
New Oncology announced that it has entered into a collaboration agreement with Gustave Roussy Cancer Campus,…
Rigontec GmbH, a German privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of…